Authors:
Belldegrun, A
Tso, CL
Zisman, A
Naitoh, J
Said, J
Pantuck, AJ
Hinkel, A
de Kernion, J
Figlin, R
Citation: A. Belldegrun et al., Interleukin 2 gene therapy for prostate cancer: Phase I clinical trial andbasic biology, HUM GENE TH, 12(8), 2001, pp. 883-892
Authors:
Rodriguez, J
Romaguera, JE
Katz, RL
Said, J
Cabanillas, F
Citation: J. Rodriguez et al., Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus, LEUK LYMPH, 41(1-2), 2001, pp. 185-189
Authors:
Lin, S
Hirschowitz, SL
Williams, C
Shintako, P
Said, J
Rao, JY
Citation: S. Lin et al., Cytokeratin 20 as an immunocytochemical marker for detection of urothelialcarcinoma in atypical cytology: Preliminary retrospective study on archived urine slides., CANCER DET, 25(2), 2001, pp. 202-209
Authors:
Elstner, E
Campbell, MJ
Munker, R
Shintaku, P
Binderup, L
Heber, D
Said, J
Koeffler, HP
Citation: E. Elstner et al., Novel 20-epi-vitamin D-3 analog combined with 9-cis-retinoic acid markedlyinhibits colony growth of prostate cancer cells, PROSTATE, 40(3), 1999, pp. 141-149
Authors:
Koike, M
Koshizuka, K
Kawabata, H
Yang, R
Taub, HE
Said, J
Uskokovic, M
Tsuruoka, N
Koeffler, HP
Citation: M. Koike et al., 20-cyclopropyl-cholecalciferol vitamin D-3 analogs: A unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines, ANTICANC R, 19(3A), 1999, pp. 1689-1697
Authors:
Koshizuka, K
Kubota, T
Said, J
Koike, M
Binderup, L
Uskokovic, M
Koeffler, HP
Citation: K. Koshizuka et al., Combination therapy of a vitamin D-3 analog and all-trans-retinoic acid: Effect on human breast cancer in nude mice, ANTICANC R, 19(1A), 1999, pp. 519-524
Authors:
Craft, N
Chhor, C
Tran, C
Belldegrun, A
DeKernion, J
Witte, ON
Said, J
Reiter, RE
Sawyers, CL
Citation: N. Craft et al., Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process, CANCER RES, 59(19), 1999, pp. 5030-5036